FUNCTIONAL MEDICINE BLOG
Includes over 800 monographs reporting on emerging studies in the medical and scientific literature of practical clinical importance, easily searched for content.
Hormone replacement in menopause and ovarian cancer risk
Hormone replacement in menopause must be evaluated thoroughly on an individual basis with careful attention to the important benefits and risks. This includes of course objective measurements of bioactive hormone levels before and during hormone replacement at appropriate intervals, including analysis of benign versus troublesome estrogen metabolites. Regarding adverse effects that must be weighed, an important study just published in The Lancet brings to light a significant risk for ovarian cancer in current and past users of hormone replacement.
Test helps select most effective chemotherapy for leukemia and other cancers
Acute myelocytic leukemia responds significantly better to chemotherapy selected by a test that shows the ability of each chemotherapeutic agent to induce apoptosis (cell death) according to research just published in the journal Leukemia & Lymphoma. This joins the list of other malignancies including breast cancer, ovarian cancer and endometrial cancer that are treated more effectively with chemotherapy screened by the microculture kinetic (MiCK) drug-induced apoptosis assay.